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高齢耐糖能異常者の糖尿病発症率とその危険因子に
関する検討
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We investigated the incidence of diabetes and risk factors for the onset of diabetes among elderly individuals
with impaired fasting glucose (IFG) who visited the Institute of Geriatrics at Tokyo Women’s Medical University
for check-ups in 2007. Among 300 individuals (mean age, 70.7±7.3 years) with fasting plasma glucose (FPG) 100-
125 mg/dl at baseline, 20 subjects (6.7 %) showed diabetes after 5 years. Of the 82 subjects with FPG 110-125 mg/
dl, which is currently used as the cut-off for IFG in Japan, 17 (20.7 %) were diabetics after 5 years. Based on logis-
tic regression analysis (stepwise method) for participants with FPG levels between 100-125 mg/dl, significant risk
factors for onset of diabetes within 5 years included hemoglobin (Hb) A1c (odds ratio (OR) 65.089, 95 % confidence
interval (CI) 4.329-978.571, p＝0.003), FPG (OR 1.141, 95 %CI 1.043-1.248, p＝0.004), AST (OR 0.816, 95 %CI 0.711-
0.936, p＝0.004), and history of stroke (OR 8.088, 95 %CI 1.109-58.987, p＝0.039). For participants with FPG levels 侒
110 mg/dl, HbA1c (OR 105.93, 95 %CI 3.658-3,068.165, p＝0.007), triglyceride (TG) (OR 1.028, 95 %CI 1.007-1.050, p＝
0.01), AST (OR 0.814, 95 %CI 0.685-0.968, p＝0.02), and history of stroke (OR 16.09, 95 %CI 1.429-181.224, p＝0.025)
were significant risk factors. These findings suggest that early intervention in lifestyle is an effective means of
preventing the onset of diabetes in elderly individuals.
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Impaired fasting glucose (IFG) was defined as fasting 
glucose level of 100-125 mg/dl.
Person who received health check in 2007                n=2094
Impaired FasƟng Glucose (IFG)                  n=852  
Age  Ӎ 60   years                                 n=515             
Person who did not receive check up in 2012
n=157
Subject                                                  n=300
Person excluded           
Already diagnosed diabetes     n=22














































た（平成 28年 8月 9日，承認番号第 4053号）．
結 果
2007年 1月から 6月の間に健診を受診した 60歳
以上の受診者のうち IFGは 515名であった．このう
ち，すでに糖尿病と診断されていたものは 22名，
HbA1c 6.1％以上のものは 36名であった（Fig. 1）．
除外基準にふれず，2012年に健診を受診したもの
は 300名（男性 222名，女性 78名）であった．Ta-
ble 1にベースライン時の患者背景を示す．年齢は
70.7±7.3歳，BMI 23.5±2.8 kg/m2，HbA1c 5.5±0.3
％，FPGは 106.9±5.8 mg/dlであった．高血圧薬物




名．女性 3名）で 6.7 %であった．
ベースライン時の FPG 5 mg/dlごとの層別に糖
尿病の発症をみると，100～105 mg/dlの 152名中 1
名（0.7％），106～110 mg/dlの 78名中 4名（5.1％），
111～115 mg/dlは 41名中 7名（17.1％），116～120
mg/dlで 22名 中 7名（31.8％），121～125 mg/dl
で 7名中 1名（14.3％）であった．また，ベースライ
ン時に，現在 IFGのカットオフ値として用いられて




ベースライン時の FPG（OR 1.205，95 %CI 1.119-
8―8―




Male, % (n) 74.0 (222)
Body mass index, kg/m2 23.5±2.8
Waist circumference, cm 86.0±7.4
Blood pressure, mmHg 124±12 / 75±9
HbA1c, % 5.5±0.3
Fasting plasma glucose, mg/dl 106.9±5.8
HOMA-R 1.44±0.77
LDL cholesterol, mg/dl 127.0±27.2





Uric acid, mg/dl 6.0±1.4
Estimated GFR, ml/min/1.73 m2 55.4±12.3
High-sensitivity CRP 0.081±0.090
Antihypertensive drug, n (%) 185 (61.7)
Statins, n (%) 125 (41.7)
History of ischemic heart disease, n (%) 27 (9.0)
History of stroke, n (%) 15 (5.0)
























発 症 は な く，5.3＜HbA1c≦5.5で は 1.1 %，5.5＜




FPG100 mg/dl以上の IFGの 5年後の糖尿病発症率





















100～125 mg/dlの IFGを 10年間フォローアップ
し，累積糖尿病発症率は FPG 110～125 ml/dlでは
17.5/1,000人年，FPG 100～110 mg/dlでは 6.2/1,000
人年とされている．デンマークの 1,821人の IFGに





FINNISH DIABETES PREVENTION STUDYでは










Table　2　Single and multiple regression analysis of risk factors for onset of diabetes in the 5 years after baseline 
(FPG levels of 100-125 mg/dl).
Independent varible
Single logistic regression analysis Multiple logistic riegression analysis
Odds ratio 95 %CI p value Odds ratio 95 %CI p value
Age 1.054 0.996-1.115 0.069
Sex (male%) 2.073 0.591-7.276 0.255
Systolic blood pressure 0.992 0.955-1.031 0.696
Diastolic blood pressure 0.996 0.943-1.052 0.882
BMI 0.965 0.823-1.131 0.658
Fasting blood glucose 1.205 1.119-1.299 ＜0.0001＊＊ 1.141 1.043-1.248 0.004
HbA1c 283.2 25.38-3,161.27 ＜0.0001＊＊ 65.089 4.329-978.571 0.003
HOMAR 0.933 0.505-1.723 0.825
High sensitive CRP 2.35 0.019-284.11 0.727
Triglyseride 1.002 0.995-1.009 0.582
LDL cholesterol 0.999 0.983-1.016 0.927
HDL cholesterol 0.986 0.956-1.017 0.378
ALT 0.93 0.869-0.996 0.039＊
AST 0.799 0.705-0.906 ＜0.0001＊＊ 0.816 0.711-0.936 0.004
γGTP 1 0.987-1.012 0.957
Estimated GFR 1.032 0.996-1.070 0.086
Uric acid 1.032 0.733-1.455 0.855
Statin use 1.157 0.468-2.881 0.754
Antihypertensive drug 0.919 0.364-2.322 0.858
Ischemic heart disease 1.882 0.515-6.884 0.339
History of stroke 3.941 1.015-15.307 0.048＊ 8.088 1.109-58.987 0.039
＊p＜0.05, ＊＊p＜0.005, ＊＊＊p＜0.0001.
Factors with p＜0.2 in the single logistic regression analysis were extracted, and multiple logistic regression analysis (step-
wise method) was performed using these factors.
IGTに対する介入研究で非介入群の糖尿病発症率




た１７）．最近行われた大規模調査で FPG 100～125 mg/
dlの 14,473人を対象にした JDOIT試験では非介入















しかし，今回の結果では IFGを FPG 100 mg/dl
以上として検討すると 5年間の糖尿病発症率は 6.7






















Table　3　Single and multiple regression analysis of risk factors for onset of diabetes in the 5 years after baseline 
(FPG levels of 110-125 mg/dl).
Independent varible
Single logistic regression analysis Multiple logistic regression analysis
Odds ratio 95 %CI p value Odds ratio 95 %CI p value
Age 1.02 0.957-1.088 0.545
Sex (male%) 2.872 0.596-13.837 0.188
Systolic blood pressure 1.008 0.958-1.606 0.77
Diastolic blood pressure 1.025 0.963-1.092 0.437
BMI 0.992 0.820-1.201 0.937
Fasting blood glucose 1.073 0.944-1.219 0.282
HbA1c 94.7 5.058-1,774.4 0.002＊＊ 105.937 3.658-3,068.165 0.007
HOMAR 0.582 0.273-1.240 0.16
High sensitive CRP 492.8 0.392-619,503.2 0.089
Triglyceride 1.017 1.002-1.032 0.024＊＊ 1.028 1.007-1.050 0.01
LDL cholesterol 1.004 0.981-1.028 0.737
HDL cholesterol 0.954 0.913-0.997 0.037
ALT 0.924 0.853-1.000 0.049＊
AST 0.819 0.706-0.950 0.008＊＊ 0.814 0.685-0.968 0.02
γGTP 0.997 0.984-1.010 0.671
Estimated GFR 1.003 0.954-1.053 0.928
Uric acid 0.991 0.694-1.415 0.959
Statin use 636 0.210-1.927 0.424
Antihypertensive drug 0.5 0.168-1.485 0.212
Ischemic heart disease 1.776 0.407-7.746 0.445
History of stroke 4.429 0.87-24,294 0.087 16.09 1.429-181.224 0.025
＊p＜0.05, ＊＊p＜0.005, ＊＊＊p＜0.0001.
Factors with p＜0.2 in the single logistic regression analysis were extracted, and multiple logistic regression analysis  (step-















125 mg/dlの IFGの 5年後の糖尿病発症率は 6.7 %，
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